Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Investment
Sort By
Newest First
1 / 11
1 / 11
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
Vetter Pharma International GmbH
PR-M10-23-03
October 17, 2023
mRNA Manufacturing
Investing in the Future of mRNA Manufacturing
Esther Yoo, Ph.D.
Samsung Biologics
PAO-11-022-CL-02
November 16, 2022
Investment
Orgenesis Secures up to USD 50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services
Orgenesis
PR-M11-22-05
November 07, 2022
Warehouse Storage
New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure
Vetter Pharma International GmbH
PR-M10-22-07
October 27, 2022
Manufacturing Investment
MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
MilliporeSigma
PR-M09-22-02
September 08, 2022
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01
September 07, 2022
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
Olon
PR-M07-22-03
July 12, 2022
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12
June 24, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02
June 24, 2022
mRNA Manufacturing
Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth
Vernal Biosciences
PR-M06-22-01-351
June 02, 2022
Decentralized Clinical Trials
uMotif – The Patient-First Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management
uMotif
PR-M05-22-13
May 25, 2022
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Derek Hennecke
Inceptor Bio
PAO-05-22-R250-09
May 24, 2022
Spray Drying
Olon Invests in New Spray Dryer at Rodano R&D Centre
Olon
PR-M05-22-11
May 17, 2022
Investment
Bringing Value to Pharma and Biopharma
Commercial Healthcare Partners
PAO-04-22-R250-75
April 29, 2022
Investment
Driving Transformational Change in the Middle Market
Excellere Partners
PAO-04-22-R250-65
April 14, 2022
Investment
Global Investment Trends and Getting Noticed by PE/VC Firms
Iesan Tsai
Kiri Capital
PAO-02-022-CL-15
March 15, 2022
Investment
Focusing on the Potential of Midsized Pharma Service Organizations
Edgewater Capital Partners
PAO-03-22-R250-03
March 02, 2022
Investment
Investment Opportunities in the Medical Device Sector
Madison Street Capital
PAO-03-22-R250-01
March 01, 2022
Private Equity
Supporting Growth for Middle-Market Companies
Jeffrey Marlough
Castleford Capital
PAO-02-22-R250-22
February 27, 2022
Biopharmaceutical Manufacturing
Investing and Expanding for High-Quality Biopharmaceuticals
Rentschler Biopharma SE
PAO-02-22-R250-19
February 24, 2022
